Avoid Stacking With Insulin Unless Supervised Stacking IGF-1 with insulin dramatically increases hypoglycemia risk and should only be done under professional guidance
Shin S, Le Lay J, Everett LJ, Gupta R, Rafiq K, Kaestner KH
Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
Since the injection acts quickly, patients often experience faster relief compared to oral supplements
No lethal dose identified at doses up to 20 mg/kg in animal studies No organ toxicity observed across multiple organ systems Negative mutagenicity testing across standard assays No teratogenic effects in pregnancy studies Limited long-term human data beyond 6 weeks Theoretical Considerations The primary theoretical concern relates to BPC-157s angiogenic properties